[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:allogeneic-stem-cell-transplantation":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":43,"states":44},"Allogeneic Stem Cell Transplantation",5,3,[8,16,23,29,36],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06453460","CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT",[12],"Phase 2","RECRUITING","2026-08-26T02:19:01.741747Z","2026-05-05T02:43:27.845688Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07613099","Evaluation of Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74 PET\u002FCT Imaging)",[20],"Phase 3","2026-08-26T02:18:00.873391Z","2026-05-29T15:36:40.234557Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT04230356","Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant",[12],"2026-08-26T02:16:41.943926Z","2026-05-05T02:43:28.418059Z",{"nct_id":30,"title":31,"phases":32,"status":33,"updated_at":34,"content_modified":35},"NCT07381205","Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)",[],"NOT_YET_RECRUITING","2026-08-26T02:17:44.240289Z","2026-05-13T02:55:06.700451Z",{"nct_id":37,"title":38,"phases":39,"status":40,"updated_at":41,"content_modified":42},"NCT05579639","Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T02:12:47.795874Z","2026-04-29T02:57:57.071455Z",[],[]]